Researchers from Kaiser Permanente in Denver have concluded that targeted age-specific computerized alerts can reduce the number of D-dimer testing needed in elderly patients, according to the study’s ...

D-dimer testing is useful for excluding venous thromboembolism (VTE), where a low D-dimer level helps exclude deep vein thrombosis (DVT) and pulmonary embolism (PE).[1][1] However, elevated levels are ...

Chicago, Feb. 03, 2026 (GLOBE NEWSWIRE) -- The global D-dimer testing market was valued at 1,500.27 million in 2023 and is expected to reach US$ 2,269.31 million by 2032, growing at a CAGR of 4.79% ...

New research suggests that it may be possible to simplify the diagnosis of deep vein thrombosis (DVT) without compromising accuracy. Contrary to the standard practice of administering several tests to ...

Tampa, FL (Oct. 26, 2021) --A screening blood test originally validated in seriously ill patients without COVID-19 is still clinically useful for ruling out pulmonary embolism in patients hospitalized ...

A targeted computerized alert at the time of physician order entry reduced the use of D-dimer testing among patients 65 years and older. A single-crossover cluster randomized trial of computerized ...

Please provide your email address to receive an email when new articles are posted on . Referring only patients with a positive D-dimer test to undergo compression ultrasonography, regardless of ...

A new study investigating D-dimer testing in patients who are at higher risk of pulmonary embolism (PE) has been published in the February issue of Academic Emergency Medicine (AEM), the peer-reviewed ...

Measurement of plasma D-dimer levels – a test more commonly used to detect blood-clotting disorders – can provide useful information when making the difficult diagnosis of periprosthetic joint ...

The growing prevalence of cardiovascular and thrombotic disorders is driving strong demand for D-dimer testing. As blood clot-related risk factors continue to increase, the need for precise diagnostic ...

(MENAFN- GlobeNewsWire - Nasdaq) The market expansion is primarily fueled by the increasing incidence of venous thromboembolism (VTE), deep vein thrombosis (DVT), pulmonary embolism (PE), and other ...